Shares of Avacta Group Plc (LON:AVCT - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 37.66 ($0.51) and traded as high as GBX 50 ($0.67). Avacta Group shares last traded at GBX 48.56 ($0.66), with a volume of 606,776 shares traded.
Avacta Group Trading Up 5.4%
The company has a debt-to-equity ratio of 52.53, a quick ratio of 4.96 and a current ratio of 1.29. The stock has a market cap of £208.20 million, a price-to-earnings ratio of -7.05 and a beta of 1.12. The company's 50 day simple moving average is GBX 40.30 and its two-hundred day simple moving average is GBX 37.74.
Avacta Group (LON:AVCT - Get Free Report) last posted its quarterly earnings results on Friday, June 6th. The biotechnology company reported GBX (8.54) earnings per share for the quarter. Avacta Group had a negative return on equity of 74.00% and a negative net margin of 114.45%. Research analysts expect that Avacta Group Plc will post -9.9011833 EPS for the current fiscal year.
About Avacta Group
(
Get Free Report)
Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.
Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).
Read More
Before you consider Avacta Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avacta Group wasn't on the list.
While Avacta Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
